127 results
Page 3 of 7
8-K
u7fet
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
0vltay n9k
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
buiv0i0
6 May 21
Adaptimmune Reports First Quarter Financial Results and Business Update
7:38am
8-K
EX-99.1
1e9m73
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am
8-K
EX-99.1
zq0ud4qof2d8htnc784
20 Nov 20
Regulation FD Disclosure
7:36am
S-3ASR
2vr0qqnl9f yy85b48l
10 Aug 20
Automatic shelf registration
5:01pm
424B5
vp1dzss0q zklta
2 Jun 20
Prospectus supplement for primary offering
5:05pm
424B5
s09m3kb6urz5
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-99.1
7060iqf
14 May 20
Adaptimmune Reports Q1 Financial Results
7:37am
8-K
EX-99.1
xse0nu nuseb2ny
12 May 20
SPEAR T-cells Derived from Stem-Cells Kill Cancer Targets - Adaptimmune Presents Advances from its Allogeneic Platform at ASGCT Annual Meeting
10:54am